New combo could cut opioid use after hip replacement
NCT ID NCT07316166
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests whether adding dexmedetomidine to a standard nerve block (using ropivacaine) improves pain control after hip replacement surgery. About 120 adults aged 18-80 will receive either the standard block or the block with added dexmedetomidine. The main goal is to see how long it takes before patients need their first painkiller after surgery.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Dexmedetomidine
- What this could lead to
- If it works, this could lead to better pain relief and less opioid use after hip surgery.
- What could go wrong
- This is a small, early-phase study, so results may not apply to everyone. Adding dexmedetomidine may cause side effects like low blood pressure or slow heart rate.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for POSTOPERATIVE PAIN MANAGEMENT are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
The Miriam Hospital
RECRUITINGProvidence, Rhode Island, 02906, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Chest surgery pain study seeks best relief strategy
- New study tests two injections to ease knee surgery pain and cut opioid use
- Eye-Opening pain relief: pupillometer may cut opioid use after surgery
- Hip surgery pain relief: which nerve block method works best?
- New hip block could match standard for Post-Surgery pain relief
- Pain education may boost shoulder surgery recovery